Oxcarbazepine is a keto-analogue of carbamazepine that exerts antiepileptic activity primarily through its active monohydroxy metabolite (MHD), offering an improved tolerability and drug-interaction profile compared to the parent drug. Simson Pharma's Oxcarbazepine reference standard and impurities support stability-indicating testing for this widely used antiepileptic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Oxcarbazepine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.